The Drug Development Process and Role of Pharmacists in Industry

Practicing pharmacists may sometimes have limited knowledge of drug development. A stronger understanding of elements in drug development processes will help pharmacists understand the larger picture contributing to drug prices, reimbursement rates, and insurance-related challenges. This session will provide an overview of the steps involved in drug development, detailing aspects of the process including clinical trials, drug testing, and approval. It also introduces additional areas where pharmacists can participate in the pharmaceutical industry, sharing opportunities for alternative career paths.

Learner Objectives

At the completion of this activity, the participant should be able to:

  • Explain the steps involved in drug development and approval
  • Describe the 4 stages of clinical drug testing
  • Identify the different functional areas where pharmacists can have impact within the pharmaceutical industry
  • Discuss how future healthcare trends in artificial intelligence, real-world evidence, and predictive models could affect both the pharmaceutical industry sector and pharmacists


Dimple Gandhi, PharmD, RPh, received her PharmD from MCPHS University and is currently pursuing her MBA in healthcare management. After exploring a variety of career paths in pharmacy, she found her passion for impacting patients through drug development and medical education. Dimple currently works within the oncology medical affairs at Takeda Pharmaceuticals.

Course Fee: Free for MCPHS alumni, full-time staff, and for all other professionals.

Release Date: March 31, 2023
Expiration Date: March 31, 2024
ACPE UAN: 0026-0000-23-006-H99-P | Knowledge
Topic Designator: Additional Topic Areas
Contact Hours: 1 (0.1 CEU)

After registering or logging into, you can view CE modules in our library.

Accreditation Council for Pharmacy Education Logo

Massachusetts College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Massachusetts College of Pharmacy and Health Sciences designates this activity for a total of 1 contact hour (0.1 CEUs).

In order to receive credit, the participant must view the entire presentation and complete the pre and post-tests, and evaluation form. Upon completion, participant credit will be reported to CPE Monitor. Transcripts may be printed from CPE Monitor.

Massachusetts College of Pharmacy and Health Sciences adheres to the ACPE Standards for Integrity and Independence in Continuing Education. It is the policy of MCPHS that the speakers and planning committee members disclose all financial relationships with ineligible companies within the last 24 months, and that relevant conflicts of interest are mitigated. Speakers will disclose any off-label/unapproved use of drugs or devices during their presentation.

Dimple Gandhi, PharmD, RPh, is an MCPHS post-doctoral Biopharmaceutical Fellow at Takeda Pharmaceuticals, an ineligible company. The content of this presentation does not relate to the product lines or solutions produced or offered by Takeda Pharmaceuticals.

Content Reviewer, Paul Belliveau, PharmD, holds no financial relationships with ineligible companies.

Massachusetts College of Pharmacy and Health Sciences Continuing Education staff members hold no financial relationships with ineligible companies, related to the content of this presentation.

No funding from industry provided for this event. No exhibitors will be present.